The clinical application of FK866 in ALI patients, especially those with elevated visfatin locally and systemically, should be explored to confirm whether the anti-visfatin approaches can improve the inflammatory changes and survival in ALI patients. The gene discussed is NAMPT; the disease is acute respiratory distress syndrome.